{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:35:22Z","timestamp":1765233322995,"version":"build-2065373602"},"reference-count":85,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"Ohio State University Office of Research and National Institutes of Health","doi-asserted-by":"publisher","award":["GM067153"],"award-info":[{"award-number":["GM067153"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Michigan Biological Sciences Scholars Program","award":["GM067153"],"award-info":[{"award-number":["GM067153"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>The severity of the COVID-19 pandemic and the pace of its global spread have motivated researchers to opt for repurposing existing drugs against SARS-CoV-2 rather than discover or develop novel ones. For reasons of speed, throughput, and cost-effectiveness, virtual screening campaigns, relying heavily on in silico docking, have dominated published reports. A particular focus as a drug target has been the principal active site (i.e., RNA synthesis) of RNA-dependent RNA polymerase (RdRp), despite the existence of a second, and also indispensable, active site in the same enzyme. Here we report the results of our experimental interrogation of several small-molecule inhibitors, including natural products proposed to be effective by in silico studies. Notably, we find that two antibiotics in clinical use, fidaxomicin and rifabutin, inhibit RNA synthesis by SARS-CoV-2 RdRp in vitro and inhibit viral replication in cell culture. However, our mutagenesis studies contradict the binding sites predicted computationally. We discuss the implications of these and other findings for computational studies predicting the binding of ligands to large and flexible protein complexes and therefore for drug discovery or repurposing efforts utilizing such studies. Finally, we suggest several improvements on such efforts ongoing against SARS-CoV-2 and future pathogens as they arise.<\/jats:p>","DOI":"10.3390\/molecules27123815","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T01:39:54Z","timestamp":1655257194000},"page":"3815","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Going Retro, Going Viral: Experiences and Lessons in Drug Discovery from COVID-19"],"prefix":"10.3390","volume":"27","author":[{"given":"Bing","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Microbiology, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dmitri","family":"Svetlov","sequence":"additional","affiliation":[{"name":"Svetlov Scientific Software, Pasadena, CA 91106, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylan","family":"Bartikofsky","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5286-0924","authenticated-orcid":false,"given":"Christiane E.","family":"Wobus","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Artsimovitch","sequence":"additional","affiliation":[{"name":"Department of Microbiology, The Ohio State University, Columbus, OH 43210, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,14]]},"reference":[{"key":"ref_1","unstructured":"(2022, June 02). UNAIDS. Available online: https:\/\/www.unaids.org."},{"key":"ref_2","unstructured":"(2022, June 02). Johns Hopkins Coronavirus Resource Center. Available online: https:\/\/coronavirus.jhu.edu."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved Antiviral Drugs over the Past 50 Years","volume":"29","author":"Li","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1021\/acs.jmedchem.6b01594","article-title":"Discovery and Synthesis of a Phosphoramidate Prodrug of a Pyrrolo[2,1-f][triazin-4-amino] Adenine C-Nucleoside (GS-5734) for the Treatment of Ebola and Emerging Viruses","volume":"60","author":"Siegel","year":"2017","journal-title":"J. Med. Chem."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2040206620976786","DOI":"10.1177\/2040206620976786","article-title":"Targeting viral genome synthesis as broad-spectrum approach against RNA virus infections","volume":"28","author":"Huchting","year":"2020","journal-title":"Antivir. Chem. Chemother."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Picarazzi, F., Vicenti, I., Saladini, F., Zazzi, M., and Mori, M. (2020). Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge. Molecules, 25.","DOI":"10.3390\/molecules25235695"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Peersen, O.B. (2019). A Comprehensive Superposition of Viral Polymerase Structures. Viruses, 11.","DOI":"10.3390\/v11080745"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1016\/j.drudis.2019.06.014","article-title":"Drug repurposing: A promising tool to accelerate the drug discovery process","volume":"24","author":"Parvathaneni","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1080\/13543776.2021.1880568","article-title":"SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19","volume":"31","author":"Vicenti","year":"2021","journal-title":"Expert Opin. Ther. Pat."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41586-021-03312-w","article-title":"SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801","volume":"591","author":"Wahl","year":"2021","journal-title":"Nature"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1038\/s41467-020-18463-z","article-title":"Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis","volume":"11","author":"Shannon","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41467-022-28113-1","article-title":"A dual mechanism of action of AT-527 against SARS-CoV-2 polymerase","volume":"13","author":"Shannon","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"16577","DOI":"10.1038\/s41598-020-73641-9","article-title":"Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir","volume":"10","author":"Jockusch","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1021\/acs.jcim.1c00384","article-title":"Comprehensive Consensus Analysis of SARS-CoV-2 Drug Repurposing Campaigns","volume":"61","author":"Mslati","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coviro.2021.03.010","article-title":"Structure and function of SARS-CoV-2 polymerase","volume":"48","author":"Hillen","year":"2021","journal-title":"Curr. Opin. Virol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.enz.2021.06.004","article-title":"CoV-er all the bases: Structural perspectives of SARS-CoV-2 RNA synthesis","volume":"49","author":"Malone","year":"2021","journal-title":"Enzymes"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"109650","DOI":"10.1016\/j.celrep.2021.109650","article-title":"The nucleotide addition cycle of the SARS-CoV-2 polymerase","volume":"36","author":"Bera","year":"2021","journal-title":"Cell Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cell.2020.11.016","article-title":"Cryo-EM Structure of an Extended SARS-CoV-2 Replication and Transcription Complex Reveals an Intermediate State in Cap Synthesis","volume":"184","author":"Yan","year":"2021","journal-title":"Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e2022310118","DOI":"10.1073\/pnas.2022310118","article-title":"Coronavirus replication-transcription complex: Vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit","volume":"118","author":"Slanina","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"8822","DOI":"10.1093\/nar\/gkab677","article-title":"NMPylation and de-NMPylation of SARS-CoV-2 nsp9 by the NiRAN domain","volume":"49","author":"Wang","year":"2021","journal-title":"Nucleic. Acids Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s42004-021-00476-4","article-title":"Mass spectrometric based detection of protein nucleotidylation in the RNA polymerase of SARS-CoV-2","volume":"4","author":"Conti","year":"2021","journal-title":"Commun. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Park, G.J., Osinski, A., Hernandez, G., Eitson, J.L., Majumdar, A., Tonelli, M., Henzler-Wildman, K., Paw\u0142owski, K., Chen, Z., and Li, Y. (2022). The mechanism of RNA capping by SARS-CoV-2. bioRxiv.","DOI":"10.1101\/2022.02.07.479471"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e0142321","DOI":"10.1128\/mBio.01423-21","article-title":"Allosteric activation of SARS-CoV-2 RdRp by remdesivir triphosphate and other phosphorylated nucleotides","volume":"12","author":"Wang","year":"2021","journal-title":"mBio"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1021\/acs.jpcb.1c00540","article-title":"Exploring the Allosteric Territory of Protein Function","volume":"125","author":"Tee","year":"2021","journal-title":"J. Phys. Chem. B"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Barakat, K., Ahmed, M., Tabana, Y., and Ha, M. (2021). A \u2018deep dive\u2019 into the SARS-Cov-2 polymerase assembly: Identifying novel allosteric sites and analyzing the hydrogen bond networks and correlated dynamics. J. Biomol. Struct. Dyn., 1\u201321.","DOI":"10.1101\/2020.06.02.130849"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.ijbiomac.2020.09.098","article-title":"Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach","volume":"163","author":"Parvez","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41579-020-00450-2","article-title":"Diverse and unified mechanisms of transcription initiation in bacteria","volume":"19","author":"Chen","year":"2020","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.2174\/156802607781212211","article-title":"Recent progress in the development of inhibitors of the hepatitis C virus RNA-dependent RNA polymerase","volume":"7","author":"Koch","year":"2007","journal-title":"Curr. Top Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Gioia, D., Bertazzo, M., Recanatini, M., Masetti, M., and Cavalli, A. (2017). Dynamic Docking: A Paradigm Shift in Computational Drug Discovery. Molecules, 22.","DOI":"10.3390\/molecules22112029"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"138889","DOI":"10.1016\/j.cplett.2021.138889","article-title":"In silico investigation to identify potential small molecule inhibitors of the RNA-dependent RNA polymerase (RdRp) nidovirus RdRp-associated nucleotidyltransferase domain","volume":"779","author":"Pitsillou","year":"2021","journal-title":"Chem. Phys. Lett."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.jmb.2013.03.034","article-title":"Role of motif B loop in allosteric regulation of RNA-dependent RNA polymerization activity","volume":"425","author":"Garriga","year":"2013","journal-title":"J. Mol. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Yuan, J., Yu, J., Huang, Y., He, Z., Luo, J., Wu, Y., Zheng, Y., Wu, J., Zhu, X., and Wang, H. (2020). Antibiotic fidaxomicin is an RdRp inhibitor as a potential new therapeutic agent against Zika virus. BMC Med., 18.","DOI":"10.1186\/s12916-020-01663-1"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Min, J.S., Kwon, S., and Jin, Y.H. (2021). SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay System. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080996"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"8416","DOI":"10.1093\/nar\/gkv838","article-title":"Discovery of an essential nucleotidylating activity associated with a newly delineated conserved domain in the RNA polymerase-containing protein of all nidoviruses","volume":"43","author":"Lehmann","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.cell.2020.07.033","article-title":"Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex","volume":"182","author":"Chen","year":"2020","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1038\/s41467-019-10280-3","article-title":"Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors","volume":"10","author":"Kirchdoerfer","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1021\/acs.chemrev.7b00145","article-title":"Enzymes Involved in AMPylation and deAMPylation","volume":"118","author":"Casey","year":"2018","journal-title":"Chem. Rev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"101018","DOI":"10.1016\/j.jbc.2021.101018","article-title":"Binding of a pyrimidine RNA base-mimic to SARS-CoV-2 nonstructural protein 9","volume":"297","author":"Littler","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.sbi.2004.10.006","article-title":"The polynucleotide ligase and RNA capping enzyme superfamily of covalent nucleotidyltransferases","volume":"14","author":"Shuman","year":"2004","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"101362","DOI":"10.1016\/j.jbc.2021.101362","article-title":"A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein","volume":"297","author":"Littler","year":"2021","journal-title":"J. Biol. Chem."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e2021946118","DOI":"10.1073\/pnas.2021946118","article-title":"Structure of the SARS-CoV-2 RNA-dependent RNA polymerase in the presence of favipiravir-RTP","volume":"118","author":"Naydenova","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Malone, B.F., Perry, J.K., Olinares, P.D.B., Chen, J., Appelby, T.K., Feng, J.Y., Bilello, J.P., Ng, H., Sotiris, J., and Ebrahim, M. (2022). Structural basis for substrate selection by the SARS-CoV-2 replicase. bioRxiv.","DOI":"10.1101\/2022.05.20.492815"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"16156","DOI":"10.1074\/jbc.AC120.015720","article-title":"Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action","volume":"295","author":"Tchesnokov","year":"2020","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"101849","DOI":"10.1016\/j.isci.2020.101849","article-title":"Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase","volume":"23","author":"Dangerfield","year":"2020","journal-title":"iScience"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e01508-20","DOI":"10.1128\/AAC.01508-20","article-title":"Development of a Simple In Vitro Assay To Identify and Evaluate Nucleotide Analogs against SARS-CoV-2 RNA-Dependent RNA Polymerase","volume":"65","author":"Lu","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"e70968","DOI":"10.7554\/eLife.70968","article-title":"Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective","volume":"10","author":"Seifert","year":"2021","journal-title":"eLife"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nchembio.1364","article-title":"The Fic protein Doc uses an inverted substrate to phosphorylate and inactivate EF-Tu","volume":"9","author":"Loris","year":"2013","journal-title":"Nat. Chem. Biol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"a027011","DOI":"10.1101\/cshperspect.a027011","article-title":"Rifamycins, Alone and in Combination","volume":"6","author":"Rothstein","year":"2016","journal-title":"Cold Spring Harb. Perspect Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2533\/chimia.2020.270","article-title":"Recent Advances in Mode of Action and Biosynthesis Studies of the Clinically Used Antibiotic Fidaxomicin","volume":"74","author":"Dorst","year":"2020","journal-title":"Chimia"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/2241280a0","article-title":"Rifampicin: A specific inhibitor of vaccinia virus assembly","volume":"224","author":"Moss","year":"1969","journal-title":"Nature"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1073\/pnas.61.2.667","article-title":"Interaction of rifamycin with bacterial RNA polymerase","volume":"61","author":"Wehrli","year":"1968","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1073\/pnas.1810398115","article-title":"Structural basis for the inhibition of poxvirus assembly by the antibiotic rifampicin","volume":"115","author":"Garriga","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41594-021-00570-0","article-title":"Structural basis for inhibition of the SARS-CoV-2 RNA polymerase by suramin","volume":"28","author":"Yin","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1080\/07391102.2020.1813628","article-title":"Potential inhibitors of SARS-cov-2 RNA dependent RNA polymerase protein: Molecular docking, molecular dynamics simulations and MM-PBSA analyses","volume":"40","author":"Elkarhat","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1021\/acsmedchemlett.0c00381","article-title":"Semisynthetic Analogs of the Antibiotic Fidaxomicin-Design, Synthesis, and Biological Evaluation","volume":"11","author":"Dorst","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/jm201716n","article-title":"Structure-based design of novel benzoxazinorifamycins with potent binding affinity to wild-type and rifampin-resistant mutant Mycobacterium tuberculosis RNA polymerases","volume":"55","author":"Gill","year":"2012","journal-title":"J. Med. Chem."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1016\/j.bmcl.2011.08.054","article-title":"Synthesis and structure-activity relationships of novel substituted 8-amino, 8-thio, and 1,8-pyrazole congeners of antitubercular rifamycin S and rifampin","volume":"21","author":"Jin","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1038\/ncomms4408","article-title":"CBR antimicrobials alter coupling between the bridge helix and the beta subunit in RNA polymerase","volume":"5","author":"Malinen","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1042\/BST20200967","article-title":"Drug repurposing in silico screening platforms","volume":"50","author":"Mullins","year":"2022","journal-title":"Biochem. Soc. Trans."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Geraghty, R.J., Aliota, M.T., and Bonnac, L.F. (2021). Broad-Spectrum Antiviral Strategies and Nucleoside Analogues. Viruses, 13.","DOI":"10.3390\/v13040667"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/34542","article-title":"A mechanism for all polymerases","volume":"391","author":"Steitz","year":"1998","journal-title":"Nature"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.molcel.2020.11.048","article-title":"Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting","volume":"80","author":"Robson","year":"2020","journal-title":"Mol. Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/em.22471","article-title":"Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis: The special case of molnupiravir","volume":"63","author":"Waters","year":"2022","journal-title":"Environ. Mol. Mutagen."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Arnold, J.J., Sharma, S.D., Feng, J.Y., Ray, A.S., Smidansky, E.D., Kireeva, M.L., Cho, A., Perry, J., Vela, J.E., and Park, Y. (2012). Sensitivity of mitochondrial transcription and resistance of RNA polymerase II dependent nuclear transcription to antiviral ribonucleosides. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1003030"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1073\/pnas.47.6.845","article-title":"The chemical and mutagenic specificity of hydroxylamine","volume":"47","author":"Freese","year":"1961","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/infdis\/jiab247","article-title":"beta-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells","volume":"224","author":"Zhou","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Tripathi, A., and Bankaitis, V.A. (2017). Molecular Docking: From Lock and Key to Combination Lock. J. Mol. Med. Clin. Appl., 2.","DOI":"10.16966\/2575-0305.106"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.1021\/acs.jproteome.0c00316","article-title":"Repurpose Open Data to Discover Therapeutics for COVID-19 Using Deep Learning","volume":"19","author":"Zeng","year":"2020","journal-title":"J. Proteome Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in Hospitalized Patients with COVID-19","volume":"384","author":"Group","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e0370521","DOI":"10.1128\/mbio.03705-21","article-title":"The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters","volume":"13","author":"Shytaj","year":"2022","journal-title":"mBio"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1128\/AAC.01168-19","article-title":"100 Years of Suramin","volume":"64","author":"Wiedemar","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e00900-20","DOI":"10.1128\/AAC.00900-20","article-title":"Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle","volume":"64","author":"Thaler","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jmb.2012.03.008","article-title":"Structure-based inhibition of Norovirus RNA-dependent RNA polymerases","volume":"419","author":"Mastrangelo","year":"2012","journal-title":"J. Mol. Biol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: A major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1093\/nar\/gkab1303","article-title":"Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: Implications for its role in viral genome stability and inhibitor identification","volume":"50","author":"Baddock","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.cell.2005.07.014","article-title":"Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins","volume":"122","author":"Artsimovitch","year":"2005","journal-title":"Cell"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0092-8674(01)00286-0","article-title":"Structural mechanism for rifampicin inhibition of bacterial rna polymerase","volume":"104","author":"Campbell","year":"2001","journal-title":"Cell"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"4758","DOI":"10.1021\/jm4004889","article-title":"X-ray crystal structures of the Escherichia coli RNA polymerase in complex with benzoxazinorifamycins","volume":"56","author":"Molodtsov","year":"2013","journal-title":"J. Med. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e34823","DOI":"10.7554\/eLife.34823","article-title":"Fidaxomicin jams Mycobacterium tuberculosis RNA polymerase motions needed for initiation via RbpA contacts","volume":"7","author":"Boyaci","year":"2018","journal-title":"eLife"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/s41429-021-00462-x","article-title":"Rifamycin antibiotics and the mechanisms of their failure","volume":"74","author":"Adams","year":"2021","journal-title":"J. Antibiot."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.sbi.2020.01.010","article-title":"Allosteric drugs and mutations: Chances, challenges, and necessity","volume":"62","author":"Guarnera","year":"2020","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Czarna, A., Plewka, J., Kresik, L., Matsuda, A., Karim, A., Robinson, C., O\u2019Byrne, S., Cunningham, F., Georgiou, I., and Wilk, P. (2022). Refolding of lid subdomain of SARS-CoV-2 nsp14 upon nsp10 interaction releases exonuclease activity. Structure.","DOI":"10.1101\/2022.02.17.480845"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Kalliokoski, T., Kramer, C., Vulpetti, A., and Gedeck, P. (2013). Comparability of mixed IC50 data\u2014A statistical analysis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061007"},{"key":"ref_85","first-page":"493","article-title":"A simple method of estimating fifty per cent endpoint","volume":"27","author":"Reed","year":"1938","journal-title":"Am. J. Hyg."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/12\/3815\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:30:58Z","timestamp":1760139058000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/12\/3815"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,14]]},"references-count":85,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["molecules27123815"],"URL":"https:\/\/doi.org\/10.3390\/molecules27123815","relation":{},"ISSN":["1420-3049"],"issn-type":[{"type":"electronic","value":"1420-3049"}],"subject":[],"published":{"date-parts":[[2022,6,14]]}}}